Literature DB >> 12540904

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype.

Claudia Kemper1, Andrew C Chan, Jonathan M Green, Kelly A Brett, Kenneth M Murphy, John P Atkinson.   

Abstract

The immune system must distinguish not only between self and non-self, but also between innocuous and pathological foreign antigens to prevent unnecessary or self-destructive immune responses. Unresponsiveness to harmless antigens is established through central and peripheral processes. Whereas clonal deletion and anergy are mechanisms of peripheral tolerance, active suppression by T-regulatory 1 (Tr1) cells has emerged as an essential factor in the control of autoreactive cells. Tr1 cells are CD4+ T lymphocytes that are defined by their production of interleukin 10 (IL-10) and suppression of T-helper cells; however, the physiological conditions underlying Tr1 differentiation are unknown. Here we show that co-engagement of CD3 and the complement regulator CD46 in the presence of IL-2 induces a Tr1-specific cytokine phenotype in human CD4+ T cells. These CD3/CD46-stimulated IL-10-producing CD4+ cells proliferate strongly, suppress activation of bystander T cells and acquire a memory phenotype. Our findings identify an endogenous receptor-mediated event that drives Tr1 differentiation and suggest that the complement system has a previously unappreciated role in T-cell-mediated immunity and tolerance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540904     DOI: 10.1038/nature01315

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  197 in total

1.  CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses.

Authors:  Steven M Truscott; Getahun Abate; Jeffrey D Price; Claudia Kemper; John P Atkinson; Daniel F Hoft
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors.

Authors:  Paul L Bollyky; Rebecca P Wu; Ben A Falk; James D Lord; S Alice Long; Anton Preisinger; Brandon Teng; Gregory E Holt; Nathan E Standifer; Kathleen R Braun; Cindy Fang Xie; Peter L Samuels; Robert B Vernon; John A Gebe; Thomas N Wight; Gerald T Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Establishment of memory for IL-10 expression in developing T helper 2 cells requires repetitive IL-4 costimulation and does not impair proliferation.

Authors:  Max Löhning; Anne Richter; Torsten Stamm; Jane Hu-Li; Mario Assenmacher; William E Paul; Andreas Radbruch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-26       Impact factor: 11.205

4.  The classical and alternative pathways of complement activation play distinct roles in spontaneous C3 fragment deposition and membrane attack complex (MAC) formation on human B lymphocytes.

Authors:  Robert Graham Quinton Leslie; Claus Henrik Nielsen
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

Review 5.  TGF-beta, T-cell tolerance and anti-CD3 therapy.

Authors:  Ramireddy Bommireddy; Thomas Doetschman
Journal:  Trends Mol Med       Date:  2004-01       Impact factor: 11.951

Review 6.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

7.  The complement receptor CD46 tips the scales in T(H)1 self-control.

Authors:  Christian M Karsten; Jörg Köhl
Journal:  Nat Immunol       Date:  2010-09       Impact factor: 25.606

8.  Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).

Authors:  Rachael Watson; Emma Wearmouth; Amy-Claire McLoughlin; Arthur Jackson; Sophie Ward; Paula Bertram; Karim Bennaceur; Catriona E Barker; Isabel Y Pappworth; David Kavanagh; Susan M Lea; John P Atkinson; Timothy H J Goodship; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2014-08-21       Impact factor: 4.407

9.  CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines.

Authors:  Milena Iacobelli-Martinez; Ronald R Nepomuceno; Jodi Connolly; Glen R Nemerow
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 10.  Function of tumor necrosis factor receptor family members on regulatory T-cells.

Authors:  Robert H Arch
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.